|
|
Atripla (Efavirenz/Tenofovir/FTC)
| Brand Name: |
Atripla |
| Generic Name: |
Efavirenz/ tenofovir/ emtricitabine, EFV/TDF/FTC |
| Adult Single Dose: |
One tablet containing 600 mg efavirenz, 300 mg tenofovir and 200 mg FTC |
| Food & Liquid Restrictions: |
Take on an empty stomach |
| Drug Class: |
1 NNRTI + 2 NRTIs |
The Basics
News
- Approval for Once-A-Day HIV Pill (December 17, 2007)
In BBC News Online, from BBC News
- FDA Approves Gilead, Bristol-Myers Squibb Once-a-Day Combination Antiretroviral Pill (July 13, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Single-Pill, Once-Daily HIV Drug Regimen Submitted for FDA Approval (April 28, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Data Supports Bioequivalence for Once-Daily, Single-Pill, Fixed-Dose Combination of Sustiva and Truvada, Drug Companies Announce (January 9, 2006)
Filing of a new drug application is expected in the second quarter of 2006.
To read PDF, click here
From Bristol-Myers Squibb Company and Gilead Sciences, Inc.
- Gilead's Fixed-Dose Combination of Truvada + Efavirenz Not Yet Bioequivalent to Drugs Alone (August 10, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
|
|
